Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK.
United Kingdom-based company, Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK, it announced in a recent press release.
“Validair is already highly regarded in its core markets across the pharmaceutical and life sciences sector,” explained Validair managing director, Steve Wake. “Now we are driving Validair’s expansion into sectors that increasingly recognize the positive impact of cleanrooms and precision contamination control in research, production, and product testing facilities.”
The £150,000 (approximately $197,000) investment was provided by the Midlands Engine Investment Fund. Through the investment, Validair will grow its number of employees to support new market applications.
“In regulated industries such as biotech, medical devices, food production, and pharma, environmental monitoring and compliance are mandated. Some newer applications less so,” added Wake. “But we see manufacturers in commercial marketplaces looking to drive-up their process quality to add value and a competitive advantage to their products. As a turnkey solutions provider, we are in the ideal position to help them deliver that value.”
Source: Validair Monitoring Solutions
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.